Melatoninergic antidepressants in the treatment of post-stroke depression

  • Viktor Kuznetsov MD, DSc (Medicine), Leading Researcher of Department of Vascular Pathology of the Brain, Department of Rehabilitation of Neurological Patients

Abstract

Abstact. The article presents data about the impact of the drug Melitor (agomelatine) on the psycho-emotional activity, cerebral hemodynamics, bioelectric activity of the brain and their intersystem connections in patients with post-stroke depression. 30 patients with post-stroke depression have been taken a dose of Melitor 25 mg per day for 2 months. It has been established that Melitor has a positive effect on psycho-emotional activity, improves cerebral hemodynamics, harmonizes the structure of bioelectric activity of the brain in patients with post-stroke depression. Melitor has more strong effect on cerebral hemodynamics and bioelectric activity of the brain in patients with right-sided stroke than among the patients with left-sided stroke. Melitor's multimodal influence justifies the use of the drug during the rehabilitation treatment of post-stroke patients for the improvement both functional and psycho-emotional state.

References

Gusev, E.I. & Skvortsova V.I. Ishemiya golovnogo mozga [Cerebral ischemia]. The medicine (in Russian): Mosсow, 2001, p 250.

Hackett, M.L.; Anderson, C.S.; House, A.O. Management of depression after stroke: a systematic review of pharmacological therapies. Stroke 2005, 36 (5), pp. 1098-1103. doi: 10.1161/01.STR.0000162391.27991.9d

Fokin, V.F.; Bogolepova I.N.; Gutnik B.E. et al. Rukovodstvo po funktsional'noy mezhpolusharnoy asimmetrii [Functional interhemispheric asymmetry guide]. Scientific world (in Russian: Moscow, 2009, p 836.

Kasper, S; Hale, A.; Lemoine, P. Depression after stroke. The Journal of the European College of Neuropsychopharmacology 2009, 19 (3), p S412.

Wayne, A.M.; Voznesenskaya, T.G.; Golubev, V.L. et al. Depressiya v nevrologicheskoy praktike (klinika, diagnostika, lecheniye) [Depression in neurological practice (clinic, diagnosis, treatment)]. Medical News Agency (in Russian): Moscow, 2007, p 198.

Emerski, E.; Robinson, R. The neuropsychiatry of stroke. Psychosomatics 2000, 41, pp. 5-14.

Smulevich, A.B. Depressii pri somaticheskikh i psikhicheskikh zabolevaniyakh [Depression in somatic and mental illness]. Medical News Agency (in Russian): Moscow, 2007, p 425.

Jeong, Y.J.; Kim, W.C.; Kim, Y.S. et al. The Relationship between Rehabilitation and Changes in Depression in Stroke Patients. Journal of Physical Therapy Science 2014, 26 (8), pp.1263-1266.

Bartoli, F.; Lillia, N.; Lax, A. et al. Depression after Stroke and Risk of Mortality: A Systematic Review and Meta-Analysis. Stroke Research and Treatment 2013, pp. 862-978. doi: 10.1155/2013/862978

Kim, J.S. Post-stroke Mood and Emotional Disturbances: Pharmacological Therapy Based on Mechanisms. Journal of Stroke 2016, 18(3), pp. 244-255. doi: 10.5853/jos.2016.01144

Brainin, M. Textbook of stroke medicine. Cambridge University Press 2010, p 190.

Savina, M.A. Klinika postinsul'tnykh depressiy [Clinic of post-stroke depression]. Mental disorders in general medicine (in Russian). Moscow 2006, 2, pp. 45-50.

Annoni, J.M.; Staub, F.; Bruggimann, L. et al. Emotional disturbances after stroke. Clin. Exp. Hypertens 2006, 28 (3-4), pp. 243-249. doi: 10.1080/10641960600549173

Robinson, R.G. & Spalletta G. Poststroke Depression: A Review. Canadian journal of psychiatry 2010, 55 (6), pp. 341-349.

Kuznrtsov, V.V. & Glushko, S. F. Sostoyaniye tserebral'noy gemodinamiki u bol'nykh s postinsul'tnoy depressiyey [The state of cerebral hemodynamics in patients with post-stroke depression]. Mental health (in Ukraine). Kyiv 2013, 2, pp. 11-17.

Mosolov, S. N. Mesto traditsionnykh antidepressantov v sovremennoy terapii depressivnykh i trevozhnykh rasstroystv [The place of traditional antidepressants in the modern treatment of depressive and anxiety disorders]. Moscow, 2005, p 28.

Geyer, J. D.; Gomez, C. R. Stroke. A practical approach. Lippicott Williams&Wilkins, 2009, p 361.

Kevin, D.; Niedens, M.; Wilson, J. Treatment outcomes of a crisis intervention program for dementia with severe psychiatric complications: the Kansas bridge project. The gerontologist 2013, 53, 1, pp. 102-112. doi: 10.1093/geront/gns104

Verdelho, A.; Henon, H.; Lebert, F. et al. Depressive symptoms after stroke and relationship with dementia. A three-year follow-up study. Neurology 2004, 62, pp. 905-911. doi: 10.1212/01.WNL.0000115107.66957.8C

Whyte, E.M.; Mulsant, B.H.; Rovner, B.W. et al. Preventing depression after stroke. Int. Rev. Psychiatr 2006, 18 (5), pp. 471-481.

Anisimov, V.N. Melatonin: rol' v organizme, primeneniye v klinike [Melatonin: role in the body, use in the clinic]. System (in Russian): St. Petersburg, 2007, p 40.

Pankaj, Sh.; Meschia, J. F. Stroke Genetics. Springer International Publishingю 2013, p 431.

Kuznetsova, S.M. & Glushko S.F. Terapiya postinsul'tnoy depressii: melatoninergicheskiye antidepressanty [Therapy for post-stroke depression: melatonergic antidepressants ]. The newspaper “Health of Ukraine” is medical (in Ukraine). Kyiv 2012, 1, 16, pp. 2-3.

Gainotti, G.; Antonucci, G.; Marra, C. Paolucci S. Relation between depression after stroke, antidepressant therapy and functional recovery. J.Neurol. Neurosurg. Psychiatry 2001, 71, pp. 258-261. doi: 10.1136/jnnp.71/2/258

Illarioshkin, S.N. & Fokin, V.F. Funktsional'naya mezhpolusharnaya asimetriya i plastichnost' mozga [Functional interhemispheric asymmetry and brain plasticity]. Мoscow, 2012, p 65.

Published
2020-10-15
How to Cite
Kuznetsov, V. (2020). Melatoninergic antidepressants in the treatment of post-stroke depression. Ageing and Longevity, 1(1). Retrieved from http://aging-longevity.org.ua/index.php/journal-description/article/view/7
Section
Статьи